VOYA Investment Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.95M | Buy |
451,125
+259,573
| +136% | +$1.96M | ﹤0.01% | 960 |
|
|
2026
Q1 | $1.47M | Buy |
191,552
+142,126
| +288% | +$973K | ﹤0.01% | 1321 |
|
|
2025
Q4 | $97.9K | Buy |
49,426
+7,049
| +17% | +$16K | ﹤0.01% | 2265 |
|
|
2025
Q3 | $104K | Sell |
42,377
-20,580
| -33% | -$53K | ﹤0.01% | 2297 |
|
|
2025
Q2 | $166K | Buy |
62,957
+23,506
| +60% | +$63.2K | ﹤0.01% | 2368 |
|
|
2025
Q1 | $119K | Sell |
39,451
-4,553
| -10% | -$13.8K | ﹤0.01% | 2394 |
|
|
2024
Q4 | $113K | Sell |
44,004
-2,572
| -6% | -$10.7K | ﹤0.01% | 2553 |
|
|
2024
Q3 | $173K | Sell |
46,576
-133,874
| -74% | -$620K | ﹤0.01% | 2525 |
|
|
2024
Q2 | $1.14M | Buy |
180,450
+136,656
| +312% | +$901K | ﹤0.01% | 1562 |
|
|
2024
Q1 | $235K | Sell |
43,794
-9,268
| -17% | -$42K | ﹤0.01% | 2381 |
|
|
2023
Q4 | $266K | Buy |
53,062
+7,073
| +15% | +$22.2K | ﹤0.01% | 2418 |
|
|
2023
Q3 | $77.7K | Buy |
45,989
+2,352
| +5% | +$4.72K | ﹤0.01% | 2787 |
|
|
2023
Q2 | $121K | Buy |
43,637
+12,221
| +39% | +$34.6K | ﹤0.01% | 2731 |
|
|
2023
Q1 | $57.2K | Hold |
31,416
| – | – | ﹤0.01% | 2784 |
|
|
2022
Q4 | $159K | Hold |
31,416
| – | – | ﹤0.01% | 2638 |
|
|
2022
Q3 | $156K | Hold |
31,416
| – | – | ﹤0.01% | 2677 |
|
|
2022
Q2 | $117K | Buy |
31,416
+5,162
| +20% | +$20.7K | ﹤0.01% | 2575 |
|
|
2022
Q1 | $147K | Hold |
26,254
| – | – | ﹤0.01% | 2436 |
|
|
2021
Q4 | $160K | Sell |
26,254
-217
| -0.8% | -$1.63K | ﹤0.01% | 2575 |
|
|
2021
Q3 | $258K | Hold |
26,471
| – | – | ﹤0.01% | 2423 |
|
|
2021
Q2 | $378K | Buy |
26,471
+12,652
| +92% | +$209K | ﹤0.01% | 2256 |
|
|
2021
Q1 | $328K | Sell |
13,819
-626
| -4% | -$16.2K | ﹤0.01% | 2275 |
|
|
2020
Q4 | $193K | Buy |
14,445
+3,718
| +35% | +$35.8K | ﹤0.01% | 2438 |
|
|
2020
Q3 | $74K | Buy |
+10,727
| New | +$107K | ﹤0.01% | 2392 |
|
|
2019
Q2 | – | Sell |
-13,481
| Closed | -$21K | – | 2597 |
|
|
2019
Q1 | $21K | Hold |
13,481
| – | – | ﹤0.01% | 2544 |
|
|
2018
Q4 | $16K | Hold |
13,481
| – | – | ﹤0.01% | 2541 |
|
|
2018
Q3 | $50K | Hold |
13,481
| – | – | ﹤0.01% | 2567 |
|
|
2018
Q2 | $41K | Hold |
13,481
| – | – | ﹤0.01% | 2601 |
|
|
2018
Q1 | $52K | Hold |
13,481
| – | – | ﹤0.01% | 2550 |
|
|
2017
Q4 | $61K | Hold |
13,481
| – | – | ﹤0.01% | 2558 |
|
|
2017
Q3 | $74K | Hold |
13,481
| – | – | ﹤0.01% | 2595 |
|
|
2017
Q2 | $102K | Buy |
+13,481
| New | +$58.2K | ﹤0.01% | 2563 |
|
Other funds holding IBRX
VOYA Investment Management's IBRX Position: Q2 2026 in Review
VOYA Investment Management increased its ImmunityBio (IBRX) stake by 136% in Q2 2026, buying an estimated $1.96M and bringing the position to 451,125 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #960.
VOYA Investment Management first reported a position in IBRX in Q2 2017 and has held it in 32 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.
- VOYA Investment Management held 451,125 shares of ImmunityBio worth $3.95M as of Q2 2026.
- VOYA Investment Management bought 259,573 ImmunityBio shares in Q2 2026, an estimated $1.96M.
- ImmunityBio made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #960 holding.
- VOYA Investment Management first reported a position in ImmunityBio in Q2 2017 and has held it in 32 quarters since.
- 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.
Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.